Spain · Delayed Price · Currency is EUR Faes Farma Statistics
Total Valuation
Faes Farma has a market cap or net worth of EUR 1.40 billion. The enterprise value is 1.71 billion.
| Market Cap | 1.40B |
| Enterprise Value | 1.71B |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | Jan 8, 2026 |
Share Statistics
Faes Farma has 311.26 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 311.26M |
| Shares Outstanding | 311.26M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 9.61% |
| Float | 229.08M |
Valuation Ratios
The trailing PE ratio is 17.76 and the forward PE ratio is 14.79. Faes Farma's PEG ratio is 1.34.
| PE Ratio | 17.76 |
| Forward PE | 14.79 |
| PS Ratio | 2.24 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 4.56 |
| P/FCF Ratio | 22.50 |
| P/OCF Ratio | 17.88 |
| PEG Ratio | 1.34 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.64, with an EV/FCF ratio of 27.37.
| EV / Earnings | 21.45 |
| EV / Sales | 2.72 |
| EV / EBITDA | 14.64 |
| EV / EBIT | 19.23 |
| EV / FCF | 27.37 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.58.
| Current Ratio | 2.61 |
| Quick Ratio | 1.60 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 3.72 |
| Debt / FCF | 6.95 |
| Interest Coverage | 19.31 |
Financial Efficiency
Return on equity (ROE) is 10.82% and return on invested capital (ROIC) is 9.58%.
| Return on Equity (ROE) | 10.82% |
| Return on Assets (ROA) | 5.06% |
| Return on Invested Capital (ROIC) | 9.58% |
| Return on Capital Employed (ROCE) | 7.68% |
| Weighted Average Cost of Capital (WACC) | 4.49% |
| Revenue Per Employee | 331,039 |
| Profits Per Employee | 42,043 |
| Employee Count | 1,894 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.39 |
Taxes
In the past 12 months, Faes Farma has paid 5.75 million in taxes.
| Income Tax | 5.75M |
| Effective Tax Rate | 6.73% |
Stock Price Statistics
The stock price has increased by +36.87% in the last 52 weeks. The beta is 0.24, so Faes Farma's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +36.87% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 4.64 |
| Relative Strength Index (RSI) | 31.25 |
| Average Volume (20 Days) | 233,507 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Faes Farma had revenue of EUR 626.99 million and earned 79.63 million in profits. Earnings per share was 0.25.
| Revenue | 626.99M |
| Gross Profit | 399.98M |
| Operating Income | 88.82M |
| Pretax Income | 85.41M |
| Net Income | 79.63M |
| EBITDA | 112.16M |
| EBIT | 88.82M |
| Earnings Per Share (EPS) | 0.25 |
Balance Sheet
The company has 130.09 million in cash and 433.29 million in debt, with a net cash position of -303.20 million or -0.97 per share.
| Cash & Cash Equivalents | 130.09M |
| Total Debt | 433.29M |
| Net Cash | -303.20M |
| Net Cash Per Share | -0.97 |
| Equity (Book Value) | 745.59M |
| Book Value Per Share | 2.39 |
| Working Capital | 297.53M |
Cash Flow
In the last 12 months, operating cash flow was 78.49 million and capital expenditures -16.11 million, giving a free cash flow of 62.39 million.
| Operating Cash Flow | 78.49M |
| Capital Expenditures | -16.11M |
| Free Cash Flow | 62.39M |
| FCF Per Share | 0.20 |
Margins
Gross margin is 63.79%, with operating and profit margins of 14.17% and 12.70%.
| Gross Margin | 63.79% |
| Operating Margin | 14.17% |
| Pretax Margin | 13.62% |
| Profit Margin | 12.70% |
| EBITDA Margin | 17.89% |
| EBIT Margin | 14.17% |
| FCF Margin | 9.95% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 3.99%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 3.99% |
| Dividend Growth (YoY) | 14.01% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 69.97% |
| Buyback Yield | -0.22% |
| Shareholder Yield | 3.77% |
| Earnings Yield | 5.67% |
| FCF Yield | 4.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 7, 2015. It was a forward split with a ratio of 1.02.
| Last Split Date | Apr 7, 2015 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Faes Farma has an Altman Z-Score of 3.02 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.02 |
| Piotroski F-Score | 3 |